Clinical Trial Update: A Phase 1/2a Study to Assess the Safety and Efficacy of CKD-516 Tab. in Combination With Irinotecan Inj. [Phase 1, Phase 2]

View source ↗

Summary

The document provides an update on a Phase 1/2a trial evaluating CKD-516 tablets in combination with irinotecan injections for colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• CKD-516 Tablet (CKD-516)
• Irinotecan Injection (irinotecan)

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Colorectal Cancer | Phase 1, Phase 2 | Status: UNKNOWN